Fourth, metabolic data (insulin, adiponectin, controlled attenuation parameter of the FibroScan, etc) were not collected at any point during follow-up, making it difficult to understand the increasing role of metabolic disorders in this patient population [38]. This evidence concerns the gene ADIPOQ and metabolic disease.